Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crown Bridge Partners, LLC acted as an unregistered securities dealer that purchased about 250 convertible notes from roughly 150 penny stock issuers and resold over 35 billion newly issued shares; as a result of SEC action, the company was ordered to cease operations, surrender all conversion rights, and pay over $9.2 million in fines and disgorgement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crown Bridge Partners.